Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study-论文-万方医学网

首页> > Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study

Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study

导出原文传递

翻译打印收藏纠错

第一作者： Mata Marin, Jose Antonio

作者： Mata Marin, Jose Antonio ^[1] ; Velasco-Penagos, Juan Carlos ^[2] ; Mauss, Stefan ^[3] ; Rodriguez-Evaristo, Mara Soraya ; Perez-Barragan, Edgar ; Villa-Platas, Joaquin ; Barragan-Huerta, Laura ; Gaytan-Martinez, Jesus Enrique

作者单位： Rising Fountains Dev ProgramEmory Univ Emory University Rollins School Public Health Rollins Sch ^[1] Ctr HIV & Hepatogastroenterol ^[2] Ctr HIV & HepatogastroenterolGen Hosp La Raza Instituto Mexicano del Seguro Social Natl Med Ctr ^[3]

关键词 Antiretroviral therapy weight integrase strand transfer inhibitor

发布时间 2024-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study

相似文献

同项目论文

相关期刊

检索历史 清除

Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study

相似文献

同项目论文

相关期刊

检索历史清除